247 related articles for article (PubMed ID: 11251814)
1. Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection.
Zhang WW; Matlashewski G
Mol Microbiol; 2001 Feb; 39(4):935-48. PubMed ID: 11251814
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection.
Zhang WW; Mendez S; Ghosh A; Myler P; Ivens A; Clos J; Sacks DL; Matlashewski G
J Biol Chem; 2003 Sep; 278(37):35508-15. PubMed ID: 12829719
[TBL] [Abstract][Full Text] [Related]
3. A2rel: a constitutively expressed Leishmania gene linked to an amastigote-stage-specific gene.
Ghedin E; Charest H; Matlashewski G
Mol Biochem Parasitol; 1998 May; 93(1):23-9. PubMed ID: 9662025
[TBL] [Abstract][Full Text] [Related]
4. Screening Leishmania donovani complex-specific genes required for visceral disease.
Zhang WW; Matlashewski G
Methods Mol Biol; 2015; 1201():339-61. PubMed ID: 25388124
[TBL] [Abstract][Full Text] [Related]
5. Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2.
Zhang WW; Matlashewski G
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8807-11. PubMed ID: 9238059
[TBL] [Abstract][Full Text] [Related]
6. In vivo selection for Leishmania donovani miniexon genes that increase virulence in Leishmania major.
Zhang WW; Matlashewski G
Mol Microbiol; 2004 Nov; 54(4):1051-62. PubMed ID: 15522086
[TBL] [Abstract][Full Text] [Related]
7. Identification and overexpression of the A2 amastigote-specific protein in Leishmania donovani.
Zhang WW; Charest H; Ghedin E; Matlashewski G
Mol Biochem Parasitol; 1996 Jun; 78(1-2):79-90. PubMed ID: 8813679
[TBL] [Abstract][Full Text] [Related]
8. Leishmania: overexpression and comparative structural analysis of the stage-regulated meta 1 gene.
Uliana SR; Goyal N; Freymüller E; Smith DF
Exp Parasitol; 1999 Jul; 92(3):183-91. PubMed ID: 10403759
[TBL] [Abstract][Full Text] [Related]
9. Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages.
Campos-Neto A; Soong L; Cordova JL; Sant'Angelo D; Skeiky YA; Ruddle NH; Reed SG; Janeway C; McMahon-Pratt D
J Exp Med; 1995 Nov; 182(5):1423-33. PubMed ID: 7595213
[TBL] [Abstract][Full Text] [Related]
10. Evidence that a naturally occurring single nucleotide polymorphism in the RagC gene of Leishmania donovani contributes to reduced virulence.
Lypaczewski P; Zhang WW; Matlashewski G
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009079. PubMed ID: 33621241
[TBL] [Abstract][Full Text] [Related]
11. Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene.
Charest H; Matlashewski G
Mol Cell Biol; 1994 May; 14(5):2975-84. PubMed ID: 7545921
[TBL] [Abstract][Full Text] [Related]
12. The developmental expression of Leishmania donovani A2 amastigote-specific genes is post-transcriptionally mediated and involves elements located in the 3'-untranslated region.
Charest H; Zhang WW; Matlashewski G
J Biol Chem; 1996 Jul; 271(29):17081-90. PubMed ID: 8663340
[TBL] [Abstract][Full Text] [Related]
13. A genomic-based approach combining in vivo selection in mice to identify a novel virulence gene in Leishmania.
Zhang WW; Peacock CS; Matlashewski G
PLoS Negl Trop Dis; 2008 Jun; 2(6):e248. PubMed ID: 18545684
[TBL] [Abstract][Full Text] [Related]
14. A Leishmania donovani gene that confers accelerated recovery from stationary phase growth arrest.
Hoyer C; Zander D; Fleischer S; Schilhabel M; Kroener M; Platzer M; Clos J
Int J Parasitol; 2004 Jun; 34(7):803-11. PubMed ID: 15157763
[TBL] [Abstract][Full Text] [Related]
15. Adaptation of Leishmania donovani to cutaneous and visceral environments: in vivo selection and proteomic analysis.
McCall LI; Zhang WW; Dejgaard K; Atayde VD; Mazur A; Ranasinghe S; Liu J; Olivier M; Nilsson T; Matlashewski G
J Proteome Res; 2015 Feb; 14(2):1033-59. PubMed ID: 25536015
[TBL] [Abstract][Full Text] [Related]
16. Screening Leishmania donovani-specific genes required for visceral infection.
Zhang WW; Matlashewski G
Mol Microbiol; 2010 Jul; 77(2):505-17. PubMed ID: 20545850
[TBL] [Abstract][Full Text] [Related]
17. Expression of a Leishmaniadonovani nucleotide sugar transporter in Leishmaniamajor enhances survival in visceral organs.
Zhang WW; Chan KF; Song Z; Matlashewski G
Exp Parasitol; 2011 Dec; 129(4):337-45. PubMed ID: 21978449
[TBL] [Abstract][Full Text] [Related]
18. The Leishmania donovani histidine acid ecto-phosphatase LdMAcP: insight into its structure and function.
Papadaki A; Politou AS; Smirlis D; Kotini MP; Kourou K; Papamarcaki T; Boleti H
Biochem J; 2015 May; 467(3):473-86. PubMed ID: 25695743
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and inhibition studies of glutamine synthetase from Leishmania donovani.
Kumar V; Yadav S; Soumya N; Kumar R; Babu NK; Singh S
Microb Pathog; 2017 Jun; 107():164-174. PubMed ID: 28351708
[TBL] [Abstract][Full Text] [Related]
20. Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey.
Özbilgin A; Harman M; Karakuş M; Bart A; Töz S; Kurt Ö; Çavuş İ; Polat E; Gündüz C; Van Gool T; Özbel Y
Acta Trop; 2017 Sep; 173():90-96. PubMed ID: 28587839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
